Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2023, 5(10); doi: 10.25236/FMSR.2023.051004.

Research Advances of the Method of Replenishing Deficiency and Removing Dirty Stasis in the Treatment of Wet Age-Related Macular Degeneration

Author(s)

Zhihua Han1, Xuemei Wu1, Lu Ji1, Yini Wu1, Sheng An2

Corresponding Author:
Sheng An
Affiliation(s)

1Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi, 710003, China

2Medical Department, Research and Development Center, Shaanxi Momentum Qixue He Pharmaceutical Co., Ltd., Xi'an, Shaanxi, 71000, China

Abstract

Wet age-related macular degeneration is a third-leading blinding eye disease that occurs mostly in people over 50 years of age, with loss of central vision as the primary symptom, and involves the macular area of the retina. By collating and analyzing literatures related to the treatment of wet age-related macular degeneration with traditional Chinese medicine in recent years, it was found that the main source of the etiology, pathogenesis, syndrome differentiation and treatment of the disease is the author's subjective clinical experience, there is no standardized and unified understanding, which makes the research results different and the treatment effect is not ideal. The article will analyze and summarize the etiology, pathogenesis, syndrome differentiation and traditional Chinese medicine treatment of wet age-related macular degeneration, which can provide drug guidance for clinical treatment and improve the therapeutic effect.

Keywords

Wet Age-Related Macular Degeneration, Chinese Medicine Treatment, Treatment Progress

Cite This Paper

Zhihua Han, Xuemei Wu, Lu Ji, Yini Wu, Sheng An. Research Advances of the Method of Replenishing Deficiency and Removing Dirty Stasis in the Treatment of Wet Age-Related Macular Degeneration. Frontiers in Medical Science Research (2023) Vol. 5, Issue 10: 23-27. https://doi.org/10.25236/FMSR.2023.051004.

References

[1] Spaide RF, Jaffe GJ, Sarraf D, et al. Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group published correction appears in Ophthalmology. Ophthalmology. 2020, 127(5):616-636. 

[2] Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014, 2(2):e106-e116

[3] Roh M, Selivanova A, Shin HJ, et al. Visual acuity and contrast sensitivity are two important factors affecting vision-related quality of life in advanced age-related macular degeneration. PLoS One. 2018, 13(5):e0196481. 

[4] Kentang Wang. Criteria of syndrome and treatment. Song Liren, collation. Beijing: People's Health Publishing House, 2014. 

[5] Qian Sheng, Zengyuan Zhuang. Zhuang Zengyuan's experience in treating age-related macular degeneration based on syndrome differentiation and staging of essence, Qi, blood and body fluid. World Journal of integrated traditional Chinese and Western medicine, 2015, 10 (05): 610-612+616 

[6] Youzhi Tang, Zhoushang Kun, Jun Feng, et al. Clinical observation of traditional Chinese medicine in the treatment of wet late age-related macular degeneration. Chinese Journal of traditional Chinese Medicine Ophthalmology, 2009, 19 (06): 340-341

[7] Huan Meng, Ming Jin. Research progress of age-related macular degeneration in traditional Chinese medicine. Beijing Traditional Chinese medicine, 2020, 39 (08): 891-895

[8] Wei Song. Guan Guohua's experience in treating senile macular degeneration. Jiangxi traditional Chinese medicine, 2008 (07): 22-23

[9] Lidong Yuan. Lanshi secret collection. Beijing: People's Medical Publishing House, 2011, 30-33

[10] Lidong Yuan. Theory of spleen and stomach. Beijing: China traditional Chinese Medicine Press, 2019: 115

[11] Jing Li, Caoming Fang. Clinical efficacy of traditional Chinese medicine combined with conbercept in the treatment of exudative age-related macular degeneration with liver and kidney deficiency. Clinical research of traditional Chinese medicine, 2021, 13 (25): 113-116

[12] Xuan Zhou. Clinical observation of Bushen Huoxue Decoction Combined with conbercept in the treatment of exudative age-related macular degeneration. New Chinese medicine, 2018, 50 (10): 140-143

[13] Qiaoling Zhang, Junjing Wang, Xiangyan Ru. Analysis of the curative effect of Jianpi Zishen fuming Decoction in the treatment of wet age-related macular degeneration. Shenzhen Journal of integrated traditional Chinese and Western medicine, 2020, 30 (02): 46-48

[14] An Liu, Caoming Fang, Lin Miao, et al. Observation on the efficacy of integrated traditional Chinese and Western medicine in the treatment of 34 cases of exudative age-related macular degeneration. Journal of Fujian University of traditional Chinese medicine, 2010, 20 (01): 6-9

[15] Lei Yu, Hong Qin. Clinical observation of Liangxue Huayu Decoction Combined with anti VEGF drugs in the treatment of wet age-related macular degeneration. Chinese Journal of Ophthalmology of traditional Chinese medicine, 2020, 30 (09): 643-647

[16] Lixia Meng, Dianke Wang. Clinical observation of Taohong Siwu Decoction Combined with intravitreal injection of ranibizumab in the treatment of wet age-related macular degeneration. reflex therapy and rehabilitation medicine, 2022, 3 (08): 27-30 

[17] Xie S, Yu Z, Lv Z. Multi-Disease Prediction Based on Deep Learning: A Survey. Computer Modeling in Engineering and Sciences, 2021, 127(3):1-34.